Tuesday’s Midday Stock Update: Organovo Holdings (ONVO), Cytokinetics (CYTK), SunPower (SPWR), Dynavax (DVAX), Inovio Pharmaceuticals (INO)

So far Tuesday, August 25, NASDAQ is down -0.69% and the S&P is down -0.18%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Organovo Holdings (ONVOResearch Report), Cytokinetics (CYTKResearch Report), SunPower (SPWRResearch Report), Dynavax (DVAXResearch Report) and Inovio Pharmaceuticals (INOResearch Report).

Organovo Holdings is up 21.29% in midday trading to $8.83. Shares opened today at $7.28. The company has a 52-week low of $3.87 and a 52-week high of $18.60. In the last 30 days, insiders have sold $17.98K worth of ONVO shares.

Cytokinetics is up 7.42% in midday trading to $24.90. Shares opened today at $23.18. The company has a 52-week low of $7.73 and a 52-week high of $29.20. On the Street’s front, the average 12-month analyst price target for the stock is $40.25, marking a 73.64% potential upside from current levels. In a report issued on August 7, Needham analyst Chad Messer reiterated a Buy rating on CYTK, with a price target of $45.00, which represents a potential upside of 94% from where the stock is currently trading. Over the last 3 months, the insider sentiment on Cytokinetics has been negative based on 60 corporate insider transactions. This sentiment is lower than the average sector sentiment of insiders.

SunPower is up 6.48% in midday trading to $12.99. Shares opened today at $12.20. The company has a 52-week low of $4.03 and a 52-week high of $15.57. On the Street’s front, the average 12-month analyst price target for the stock is $8.61, marking a -29.43% potential downside from current levels. In a report issued on August 14, Morgan Stanley analyst Stephen Byrd maintained a Sell rating on SPWR, with a price target of $5.30, which reflects a potential downside of -57% from last closing price. Separately, on August 6, Credit Suisse’s Michael Weinstein W. maintained a Buy rating on the stock and has a price target of $13.00. In the last 30 days, insiders have sold $122.9K worth of SPWR shares. Over the last 3 months, the insider sentiment on SunPower has been negative based on 59 corporate insider transactions. This sentiment is lower than the average sector sentiment of insiders.

See today’s analyst top recommended stocks >>

Dynavax is up 6.4% in midday trading to $6.32. Shares opened today at $5.94. The company has a 52-week low of $1.80 and a 52-week high of $12.44. On the Street’s front, the average 12-month analyst price target for the stock is $15.33, marking a 158.08% potential upside from current levels. In a report issued on August 20, William Blair analyst Matt Phipps reiterated a Buy rating on DVAX. Over the last 3 months, the insider sentiment on Dynavax has been positive based on 14 corporate insider transactions. This sentiment is slightly higher than the average sector sentiment of insiders.

See today’s analyst top recommended stocks >>

Inovio Pharmaceuticals is up 6.39% in midday trading to $12.48. Shares opened today at $11.73. The company has a 52-week low of $1.92 and a 52-week high of $33.79. On the Street’s front, the average 12-month analyst price target for the stock is $15.60, marking a 32.99% potential upside from current levels. In a report issued on August 18, RBC analyst Gregory Renza maintained a Hold rating on INO, with a price target of $12.00, which represents a slight upside potential from current levels. Separately, on August 11, Cantor Fitzgerald’s Charles Duncan maintained a Buy rating on the stock and has a price target of $31.00.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.